Articles

  • Jul 24, 2024 | brnw.ch | Jack O’Brien

    Lina Polimeni, Eli Lilly and Company’s chief corporate brand officer, tells senior editor Jack O’Brien how the drugmaker will use a marketing push at the 2024 Paris Summer Olympics to build authentic relationships and burnish its image. In our Trends segment, we explore how President Joe Biden dropping out of the 2024 presidential race affects the Democrats’ approach to health policy.

  • Jun 12, 2024 | brnw.ch | Lecia Bushak |Jack O’Brien

    Carolee Lee, CEO/founder of Women’s Health Access Matters (WHAM), previews her keynote at this week’s 2024 MM+M Women of Distinction ceremony, telling Lecia Bushak she wants to bolster women-focused medical research by changing the dialogue from social justice to data-driven economics. Lecia also sums up state-based efforts to regulate AI in healthcare, while health-related showings at this year’s Tribeca Film Festival top our Trends segment.

  • Jun 4, 2024 | brnw.ch | Larry Dobrow |Jack O’Brien

    On this week’s show, devoted entirely to previewing the 2024 MM+M Agency 100 issue, MM+M’s Larry Dobrow joins Jack O’Brien, Lecia Bushak and Marc Iskowitz to explain the uniqueness of this year’s edition, from the sports-inspired visuals to the top agency trends, stats and more. Reminder: the digital package debuts on Tuesday, June 11.

  • May 30, 2024 | brnw.ch | Jack O’Brien

    Marc Iskowitz interviews Dr. Brian Anderson, CEO/co-founder of Coalition for Health AI (CHAI), about the group’s progress on health-AI ethics rules, as well as a deal to launch its inaugural summit at HLTH later this year. Lecia Bushak discusses the “dark money” group using social media to lobby for passage of a bill limiting U.S. business with certain Chinese biotechs.

  • May 8, 2024 | brnw.ch | Jack O’Brien |Lecia Bushak

    Digital Editor Jack O’Brien interviews Seattle Children’s Candi Nicholson and Little Hands of Stone’s Michael Boychuk about their recent PSA, which urges Gen X parents to just ask their Gen Z kids about suicide. Senior reporter Lecia Bushak offers an update on the pharma industry’s IRA legal setback, as well as Sen. Bernie Sanders’ inquiry into the prices of Novo Nordisk’s GLP-1 drugs.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →